Mineralys Share Price

Mineralys Share Price

NASDAQ: MLYS | Small Cap | Healthcare
$13.67
-$0.45 (-3.19%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Mineralys Stock Performance

Open
$13.69
Prev. Close
$14.12
Circuit Range
N/A
Day Range
$13.57 - $14.74
Year Range
$13.57 - $44.99
Volume
64,444
Average Traded
$13.90

Mineralys Share Price Today

As of 21 November 2026, Mineralys Therapeutics, Inc.'s share price is $13.67. The stock opened at $13.69, compared to its previous close of $14.12. During today's trading session, Mineralys Therapeutics, Inc.'s share price traded between $13.57 and $14.74, with an average price of $14.16. Over the past 52 weeks, the stock has recorded a high of $44.99 and a low of $13.57. In terms of performance, Mineralys Therapeutics, Inc.'s share price has declined by 56.52% over the last six months and is down 68.33% on a year-on-year basis.

Mineralys Share Price Chart

Line chart of the Mineralys price trend over the selected period. The price fell overall, ranging from 13.58 to 14.74, ending at 13.66.
$13.57$14.74
L
Show Current Price
H

Mineralys Stock Fundamentals & Key Indicators

Market Cap
$924.86M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.18
Revenue (TTM)
$0.00
Return On Equity (TTM)
-73.44%
Profit Margin
N/A
Debt to Equity
0.20
Quarterly Earnings Growth YoY
-77.88%

Mineralys Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$32.23-$39.34-$241.07-$57.33
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.06%-512.79%76.22%

Mineralys Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$71.90-$177.81-$154.65
Net Profit MarginN/AN/AN/A
Income ChangeN/A-147.30%13.03%

Mineralys Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.420.552.53
Current Assets661.39205.35249.1
Total Assets661.81205.9251.64
Non Current Liabilities0.00.00.0
Current Liabilities15.1114.6510.48
Total Liabilities15.1114.6510.48
Shareholders' Equity646.69191.26241.15

Mineralys Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-142.42-166.31-81.17
Investing-389.75114.96-160.47
Financing591.0116.14203.25

About Mineralys

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Mineralys Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$18.22
$13.67
-24.58%
Oct 2026
$24.91
$18.13
-28.00%
Sep 2026
$25.43
$25.18
-3.17%
Aug 2026
$25.48
$26.00
+1.94%
Jul 2026
$26.63
$25.50
-5.54%
Jun 2026
$31.08
$27.00
-14.12%
May 2026
$27.97
$31.44
+17.73%
Apr 2026
$28.22
$26.70
-1.38%
Mar 2026
$28.87
$27.08
-7.51%
Feb 2026
$31.27
$29.28
-5.12%
Jan 2026
$36.30
$30.86
-14.89%
Dec 2025
$43.03
$36.26
-16.01%

Mineralys Share Price FAQs